基因治疗的障碍,了解血友病患者的担忧:一个必需的子研究
Simon Fletcher1,2, Kathryn Jenner3, Michael Holland3
1Haemnet, London, N15 3JR, UK. sfletcher26@aol.com.
Orphanet journal of rare diseases
|February 10, 2024
概括
基因疗法为血友病 (PwH) 患者提供了希望,但仍然存在进入障碍. 了解患者对期望,结果,获取和教育的担忧对于更广泛的采用至关重要.
科学领域:
- 血液学 血液学 血液学
- 基因治疗 基因治疗
- 患者的观点 患者的观点
背景情况:
- 基因疗法为血友病提供了潜在的治疗方法,可以摆脱出血和当前的治疗负担.
- 获得基因治疗的机会仅限于临床试验,由于符合条件,许多血友病患者 (PwH) 被排除在外.
- 这项研究解决了需要了解没有获得基因治疗的PwH的观点.
研究的目的:
- 探索英国血友病患者对基因疗法的理解,担忧和感知障碍.
- 确定影响普华永道关于采用基因治疗的决策过程的关键因素.
主要方法:
- 一项定性研究,涉及采访血友病患者 (PwH) 和一名家庭成员.
- 参与者从一个以前没有接触过基因疗法的英国队列中招募.
主要成果:
- 鉴定了基因疗法的四个主要障碍:对过程的担忧 (期望),对结果 (结果) 的不确定性,治疗可访问性 (访问) 和缺乏理解 (教育).
- 参与者普遍认为基因疗法是积极的,但强调了这四个关键问题,影响了他们接受治疗的意愿.
结论:
- 基因疗法被认为是改善血友病患者生活质量的有希望的进步.
- 解决与期望,结果,获取和教育相关的患者担忧对于实现基因治疗的全部潜力至关重要.
- 医疗保健专业人员,患者组织和提供者之间的合作是必要的,以克服已识别的障碍.
相关概念视频
Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K
Genome-wide Association Studies-GWAS
13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.4K
Disorders of Hemostasis
911
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
911


